Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa - Wikidata - wikimedia - TriplyDB

Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa

Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa

http://www.wikidata.org/entity/Q33707291

about

Implication of First-Line Antiretroviral Therapy Choice on Second-Line Options.Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital

P2860

Q47098773-BFE96F23-9BDE-4FE3-97E0-3E2F23E89688 Q58122670-C677CBEF-E5B6-4838-B620-D5C16DEEF38B

P2860

Tenofovir or zidovudine in second-line antiretroviral therapy after stavudine failure in southern Africa

http://www.wikidata.org/entity/Q33707291

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Tenofovir or zidovudine in sec ...... ine failure in southern Africa

@ast

Tenofovir or zidovudine in sec ...... ine failure in southern Africa

@en

type

label

Tenofovir or zidovudine in sec ...... ine failure in southern Africa

@ast

Tenofovir or zidovudine in sec ...... ine failure in southern Africa

@en

prefLabel

Tenofovir or zidovudine in sec ...... ine failure in southern Africa

@ast

Tenofovir or zidovudine in sec ...... ine failure in southern Africa

@en

P1433

Q33707291-B5A39E7F-D65A-4F9A-A0A7-0DF7C00B5068

P1476

Q33707291-8267E258-87EC-4FCB-A0A4-3DA815C187D1

P2093

Q33707291-194EAA94-FADB-4474-8406-BD80A1343F77

Q33707291-19BC9567-431C-4FFB-9BA5-9E8688596BBA

Q33707291-256A348C-E396-460A-B8DD-B092B088C1AD

Q33707291-26B93AAB-B43B-442F-9B79-344DCA6D8670

Q33707291-3618AEA1-A477-4748-88FB-87C102A5FE13

Q33707291-5C912A52-EA5E-4340-9DDE-CB79D1CEAC6D

Q33707291-85CEA764-A998-4167-997E-A404E551E4CC

P2860

Q33707291-0B289F86-7136-4C7C-9446-A022EC6A812D

Q33707291-0B9D8B06-ADAB-459F-B5D5-D58DD6359FC8

Q33707291-0C8D38B0-1BD8-4FE3-BB04-2CE562691549

Q33707291-109060BA-6B36-4B9C-8480-83D50F4D4D0D

Q33707291-177F0E64-0074-4D65-8F83-3BC9CCF0F7F2

Q33707291-23F7B018-2D6B-4CE9-A9B1-91030922D637

Q33707291-3946F7F6-C151-46A1-B3B3-8C4192B0449A

Q33707291-8C6458A4-C415-4518-B79B-051E9D81C573

Q33707291-A8995893-17AE-4B64-A071-B329F84A6178

Q33707291-B27A3FF9-A505-4E98-9A11-F1A53B01433A

P304

Q33707291-EFA2E893-1FBB-42F2-9D58-9D6311767E61

P31

Q33707291-8438ACD8-A9B8-4369-B083-A8E28F8E7FB8

P356

Q33707291-DF6DCD0A-66FD-4AB1-8F15-FE69A77CFC9B

P433

Q33707291-A4814722-3A0A-410C-8261-2044A1A6E474

P478

Q33707291-32699518-5C59-49DE-94A1-5DB3BB22F2E2

P50

Q33707291-0BB93884-7389-4730-BF4B-18FAC75377D0

Q33707291-2828F84B-FC7E-4981-9DA8-769B4C87AD40

Q33707291-3407119B-4C6A-4A09-A802-E67DFBF25249

Q33707291-3CFF8887-CB31-4DD7-9627-9E4012B952F6

Q33707291-4BDDB80C-21B4-4936-9DA5-58FB7A8E7EA5

Q33707291-58C8BC1D-9C60-4B9E-9105-F66D7100E67A

Q33707291-E2A42907-842D-4DE1-8073-D8BA59211E52

P577

Q33707291-6272DBF2-5A01-41AF-8200-52712BC2FC7A

P698

Q33707291-BBCCB360-C5AA-4DDD-849A-DCFA40F616A1

P921

Q33707291-4F7BE5F0-B891-4798-B36D-848D5E3E0172

Q33707291-76871056-442C-4391-B194-F5C55696D54E

P932

Q33707291-2308F9F8-066F-4CFD-A6CB-0A32EBF7B5B1

P356

P1433

Antiviral Therapy

P1476

Tenofovir or zidovudine in sec ...... ine failure in southern Africa

@en

P2093

Benjamin H Chi

http://www.w3.org/2001/XMLSchema#string

Cleophas Chimbetete

http://www.w3.org/2001/XMLSchema#string

Gilles Wandeler

http://www.w3.org/2001/XMLSchema#string

IeDEA Southern Africa

http://www.w3.org/2001/XMLSchema#string

Julia Rohr

http://www.w3.org/2001/XMLSchema#string

Matthew P Fox

http://www.w3.org/2001/XMLSchema#string

Thomas Gsponer

http://www.w3.org/2001/XMLSchema#string

P2860

Marginal structural models and causal inference in epidemiology

The K65R mutation in HIV-1 reverse transcriptase: genetic barriers, resistance profile and clinical implications.

The public health approach to identify antiretroviral therapy failure: high-level nucleoside reverse transcriptase inhibitor resistance among Malawians failing first-line antiretroviral therapy.

Outcomes after virologic failure of first-line ART in South Africa

Tenofovir in second-line ART in Zambia and South Africa: collaborative analysis of cohort studies

Cohort Profile: the international epidemiological databases to evaluate AIDS (IeDEA) in sub-Saharan Africa.

Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

Constructing inverse probability weights for marginal structural models.

Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies.

P304

521-525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3851/IMP2710

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

Hans W. Prozesky

Catherine Orrell

Christopher J Hoffmann

P577

2013-12-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24296645

http://www.w3.org/2001/XMLSchema#string

P921

Southern Africa

antiretroviral drug

P932

4043936

http://www.w3.org/2001/XMLSchema#string